Pathogenic antibodies to coagulation factors. Part II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor

This publication has 64 references indexed in Scilit:

• Relative Purity of Thrombin-Based Hemostatic Agents Used in Surgery
  Journal of the American College of Surgeons, 2003
• Factor V Inhibitor after Injection of Human Thrombin (Tissucol) into a Bleeding Peptic Ulcer
  Endoscopy, 2003
• A thrombin–cross‐reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C
  Arthritis & Rheumatism, 2003
• Exposure of Mice to Topical Bovine Thrombin Induces Systemic Autoimmunity
  The American Journal of Pathology, 2001
• Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis
  American Journal of Hematology, 1994
• The rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B release
  British Journal of Haematology, 1991
• Intracerebral haemorrhage due to acquired factor XIII inhibitor???successful response to factor XIII concentrate
  Blood Coagulation & Fibrinolysis, 1991
• An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.
  Journal of Clinical Investigation, 1991
• A Fatal Thrombotic Disorder Associated with an Acquired Inhibitor of Protein C
  New England Journal of Medicine, 1987
• Acquired factor XI inhibitors in congenitally deficient patients
  American Journal of Hematology, 1987